Boots UK to offer more affordable generic hormonal contraceptive

Consumer Healthcare News

Boots UK has announced that it will be offering a new and more affordable generic therapy to underpin its emergency hormonal contraceptive (EHC) service.

In response to customer feedback, the pharmacy chain has been making efforts to source a less expensive EHC medicine to ensure its privately-funded EHC service can be made more accessible in future.

“Boots UK is rolling out a new and more affordable generic version of levonorgestrel as part of its emergency hormonal contraception service.“

Having commenced the rollout of this service to 38 stores last month, the company has selected generic levonorgestrel as its contraceptive of choice, and has been working with the manufacturer to increase supply.

As such, it will be able to begin offering this service across all 2,500 of its Boots stores from October 2017 onwards, having waited to confirm supply details and a rollout date before making a public announcement.

The generic levonorgestrel will be offered alongside Ella One, Levonelle and the Boots Pharmaceuticals version of Levonelle.

A Boots UK spokesperson added: "We continue to believe that the best way to increase access of EHC is for a free NHS service to be made available to all women for the provision of EHC in England, as it is in Scotland and Wales."

With over 20 years of experience within the consumer market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current consumer roles we have available, you can search for the latest job roles, register your details, or contact the team today.

See all the latest jobs in Consumer
Return to news